Tesamorelin
A stabilized GHRH(1-44) analog studied for growth-hormone-axis and lipid metabolism.
Research Overview
Tesamorelin is a stabilized analog of the full-length growth-hormone-releasing hormone GHRH(1-44). As a GHRH-receptor agonist it is studied for stimulation of endogenous growth-hormone secretion and downstream IGF-1 signaling.
Research models also examine its relationship to visceral-lipid and metabolic endpoints associated with the GH–IGF-1 axis.
Specifications
| Compound | Tesamorelin (TH9507) |
| Classification | Endocrine research compound |
| Molecular weight | 5,135.9 g/mol |
| Sequence / Form | Stabilized GHRH(1-44) |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
